Viewing Study NCT05789667


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2025-12-26 @ 1:38 PM
Study NCT ID: NCT05789667
Status: RECRUITING
Last Update Posted: 2024-12-06
First Post: 2023-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Sponsor: Regina Elena Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module